349 results on '"Senitzer, David"'
Search Results
2. Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
3. Significance of Ethnicity in the Risk of Acute Graft-versus-Host Disease and Leukemia Relapse after Unrelated Donor Hematopoietic Stem Cell Transplantation
4. Hematopoietic Cell Transplantation with Cord Blood for Cure of HIV Infections
5. Impact of Graft-Versus-Graft Natural Killer Cell Alloreactivity on Single Unit Dominance After Double Umbilical Cord Blood Transplantation
6. KIR2DS5 in the presence of HLA-C C2 protects against endometriosis
7. Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis
8. Two New Cases of KIR3DP1, KIR2DL4-Negative Genotypes, One of which is also Lacking KIR3DL2
9. Expression of Activating KIR2DS2 and KIR2DS4 Genes after Hematopoietic Cell Transplantation: Relevance to Cytomegalovirus Infection
10. One-Antigen Mismatched Related versus HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Adults with Acute Leukemia: Center for International Blood and Marrow Transplant Research Results in the Era of Molecular HLA Typing
11. HLA-C C1C2 heterozygosity may protect women bearing the killer immunoglobulin-like receptor AA genotype from spontaneous abortion
12. A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens
13. Rapid, Flow Cytometric Assay for NK Alloreactivity Reveals Exceptions to Rules Governing Alloreactivity
14. Reduced-Intensity Conditioning followed by Peripheral Blood Stem Cell Transplantation for Adult Patients with High-Risk Acute Lymphoblastic Leukemia
15. The Effect of Single and Combined Activating Killer Immunoglobulin-like Receptor Genotypes on Cytomegalovirus Infection and Immunity after Hematopoietic Cell Transplantation
16. Impact of Graft Cell Dose on Transplant Outcomes following Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplantation: Higher CD34 + Cell Doses Are Associated with Decreased Relapse Rates
17. Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation
18. Chimerism Testing by Quantitative PCR Using Indel Markers
19. Detrimental Effect of Natural Killer Cell Alloreactivity in T-replete Hematopoietic Cell Transplantation (HCT) for Leukemia Patients
20. Identification of new MHC-restriction elements for presentation of the p210BCR-ABL fusion region to human cytotoxic T lymphocytes
21. [8] Role for Killer Immunoglobulin-like Receptors and/or their Ligands in Hematopoietic Stem Cell Transplantation (HCT).
22. Hematopoietic Stem-Cell Contribution to Ectopic Skeletogenesis
23. The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population
24. P010 Heterogeneous flow cytometry crossmatch reactions in the presence of patient sera with pan-dr antibodies
25. P011 HLA-B13 donor-specific antibodies yield atypical flow cytometry crossmatch outcomes
26. Immunologic aspects of renal transplantation
27. Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status
28. P049 Anti-angiotensin II Type-1 receptor antibodies in failed chimerism after hematopoietic stem cell transplantation
29. P262 Dna sequencing with Scisco genetics next generation sequencing HLA typing version 5 kit
30. Impact of CYP3A5/CYP2C19 Pharmacogenetics on Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) Using Tacrolimus/Sirolimus (Tac/Sir) as Graft Versus Host Disease (GVHD) Prophylaxis
31. Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses
32. P067 How different is gamma block in HLA matched (10/10) unrelated pairs detected by next generation sequencing (NGS)?
33. P106 Killer immunoglobilun-like receptors (KIR) BB haplotype confers susceptibility to acute childhood lymphoblastic leukemia (ALL) and 2DS2, 2DS3 and 2DS4 activating genes are of low risk in mexican children
34. New insights on the natural killer cell repertoire from a thorough analysis of cord blood cells
35. Tacrolimus/Sirolimus (T/S)-Based GvHD Prophylaxis Does Not Overcome Poor Outcome of HLA Mismatch after Unrelated Donor (URD) Peripheral Blood Stem Cell Transplantation
36. Impact of Donor Activating KIR2DS5 and KIR2DS2 on Outcome of Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Patients with Acute Myeloid Leukemia (AML)
37. Deleterious Effect of High-Expression HLA-DPB1 Allele Mismatch in Patients (pts) Undergoing 10/10 Match Unrelated Donor (MUD) Hematopoietic Cell Transplant (HCT) for Hematological Malignancies
38. Identification of two novel HLA-B null alleles using next generation sequencing
39. KIR shapes HLA
40. How masked high-titer HLA antibodies change in highly sensitized patients after Hematopoietic Stem Cell Transplantation (HSCT)
41. Protein A-binding immunosuppressive mouse serum factors
42. Expression of Activating KIR2DS2 and KIR2DS4 genes following hematopoietic cell transplant (HCT): relevance to cytomegalovirus (CMV) infection
43. LBP12
44. The role of KIR gene content and HLA-C group in susceptibility to HTLV-1-associated myelopathy / tropical spastic paraparesis in Peru
45. Drug Metabolism Gene Polymorphisms Influence Tacrolimus/Sirolimus Blood Levels and Incidence of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
46. Reduced Relapse Risk in Acute Myelogenous Leukemia (AML) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Patients Who Experienced CMV Reactivation: Influence of Donor KIR Genotypes
47. Analysis of graft survival in a trial of stem cell transplant in ALS
48. P088
49. 71 - Impact of CYP3A5/CYP2C19 Pharmacogenetics on Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) Using Tacrolimus/Sirolimus (Tac/Sir) as Graft Versus Host Disease (GVHD) Prophylaxis
50. Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.